Frazier Healthcare Partners

Venture Capital

Healthcare-focused private equity and venture capital firm investing across the healthcare industry.

Profile

Founded
1991
Headquarters
Seattle, US
Investments
2
Companies
1

Capital

Total Deployed
$127M
Lead Rounds
0
Website
www.frazierlife.com

Portfolio

1 company
Pardes Biosciences $127M
Acquired Carlsbad, US

Clinical-stage biopharmaceutical company that developed novel oral antiviral therapeutics targeting COVID-19. Went public via SPAC merger in 2021 before being acquired by MediPacific (a Foresite Capital affiliate) in 2023 after its lead candidate failed Phase 2 trials.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.